The Strategic Questions Reshaping the CDMO Map
January 22, 2026
We sit down with Joerg Ahlgrimm, CEO of SK pharmteco, to discuss his career and the changing landscape for outsourcing
9 min read
False
The voices driving change and progress in medicine making. Explore stories, interviews, and community highlights that inspire and inform.
We interview Scott Billman, one of the judges of the ISPE Facility of the Year Awards, to learn more about the 2025 winners and the trends impacting facilities.
All the latest Medicine Maker articles.
January 19, 2026
More experts share their thoughts on the next “big ideas” that they think will shape the near future of therapy developments.
10 min read
January 19, 2026
First-in-class monoclonal antibody agonist program for inflammation
2 min read
January 16, 2026
New leader will be based at the company’s new global headquarters in Singapore
1 min read
January 15, 2026
About the Pediatric Praziquantel Consortium, and why a child-friendly treatment for preschool-aged children with schistosomiasis was needed
13 min read
January 14, 2026
For CDMOs, the storms of de-industrialization, Brexit, and the Biosecure Act are not existential threats but the very winds that can propel them forward.
4 min read
January 14, 2026
In short: Yes, says Mat Minardi, Chief Scientific Officer at Sterling Pharma Solutions
7 min read
January 13, 2026
Are developers still underestimating the engineering sophistication required to scale advanced therapies in the real world? Alan Boyd discusses.
7 min read
January 12, 2026
New capability frees up human capital from one of the biggest labor costs in clinical research
1 min read
January 12, 2026
Here’s why so many people in the industry are excited about the potential of radiopharmaceuticals for diagnosis and treatment.
5 min read
January 9, 2026
Catalent offers clarification after recent discussions raised concerns around softgels, phthalates and potential health risks
3 min read
False